ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
1,601
Screening encounters
1,699
Diagnostic referrals
321
Outstanding pathways
148

Screening pathway

  1. Screening1,699Encounters
  2. Positive finding566Documented findings
  3. Referral321Diagnostic referrals
  4. Follow-up340Diagnostic visits
  5. Outcome173Resolved pathways

Stage totals use different units. Pending pathways: 148. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3232 · EXP-3232Synthetic · Site B

Full participant history through 2025-10-18, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-03-20
  4. · Diagnostic referral · EXP-3232-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Unsuccessful
  8. · Contact attempt · Reached

Referral-time risk

Pathway status at observation · Pending

Loading prediction…

Screened participants

1601 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4691 · Expanded synthetic participant 4691Site D — Community Engagement Programme
EXP-4692 · Expanded synthetic participant 4692Site D — Community Engagement Programme
EXP-4699 · Expanded synthetic participant 4699Site B — Peri-Urban Access Programme
EXP-4701 · Expanded synthetic participant 4701Site A — Urban Referral Hub
EXP-4707 · Expanded synthetic participant 4707Site E — Resource-Constrained Navigation Programme
EXP-4710 · Expanded synthetic participant 4710Site C — Rural Outreach Programme
EXP-4711 · Expanded synthetic participant 4711Site B — Peri-Urban Access Programme
EXP-4715 · Expanded synthetic participant 4715Site C — Rural Outreach Programme
EXP-4716 · Expanded synthetic participant 4716Site E — Resource-Constrained Navigation Programme
EXP-4719 · Expanded synthetic participant 4719Site D — Community Engagement Programme
EXP-4723 · Expanded synthetic participant 4723Site A — Urban Referral Hub
EXP-4734 · Expanded synthetic participant 4734Site A — Urban Referral Hub
EXP-4736 · Expanded synthetic participant 4736Site B — Peri-Urban Access Programme
EXP-4737 · Expanded synthetic participant 4737Site E — Resource-Constrained Navigation Programme
EXP-4738 · Expanded synthetic participant 4738Site C — Rural Outreach Programme
EXP-4739 · Expanded synthetic participant 4739Site B — Peri-Urban Access Programme
EXP-4741 · Expanded synthetic participant 4741Site A — Urban Referral Hub
EXP-4747 · Expanded synthetic participant 4747Site B — Peri-Urban Access Programme
EXP-4748 · Expanded synthetic participant 4748Site E — Resource-Constrained Navigation Programme
EXP-4756 · Expanded synthetic participant 4756Site B — Peri-Urban Access Programme
EXP-4763 · Expanded synthetic participant 4763Site A — Urban Referral Hub
EXP-4764 · Expanded synthetic participant 4764Site B — Peri-Urban Access Programme
EXP-4768 · Expanded synthetic participant 4768Site E — Resource-Constrained Navigation Programme
EXP-4769 · Expanded synthetic participant 4769Site D — Community Engagement Programme
EXP-4770 · Expanded synthetic participant 4770Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
721
HPV DNA
734
Cytology
244

Navigation activity

Barrier documented
270
Contact attempt
468
Navigation intervention
112
Diagnostic booking
392
Diagnostic visit
340

Documented barriers

Contact difficulty
84
Transport difficulty
92
Appointment coordination
94

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.